الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 116 |  |  |
| | | from | 116 | | |
Abstract
One of the greatest challenges in obstetrics is to manage early fetal growth restriction. At present, a combination of several different monitoring modalities is used, including arterial and venous Doppler ultrasonography plus assessment of short term fetal heart rate variation. There is no consensus which one of these parameters should trigger delivery (Baschat et al., 2001).
Magnesium sulfate is used for the treatment of severe preeclampsia and can help to prevent serious complications (Euser & Cipolla, 2009). It is hypothesized that and according to the previous results by (Negin et al., 2012) infusion of Magnesium sulphate in cases of sever preeclampsia significantly decreases the fetal PI of the umbilical and middle cerebral arteries & increase the cerebro-placental ratio indices obtained with color Doppler ultrasound evaluations, so we hypothesized that it could be beneficial according to the previous finding that the use of Magnesium Sulphate could improve the umbilical & cerebral blood flow in cases of patients with IUGR that have elevated Doppler indices.
The study was designed in a prospective manner and the aim of this study was to compare the neonatal outcomes in relation to the elevated Doppler parameters of the UA & MCA after infusion of Magnesium sulphate and how this can help in triaging the patient to specific care in low resource settings.
This study was conducted at Minya Maternity Hospital on 44 pregnant women with singleton pregnancy attending for routine examination at 28-34 weeks. The criteria of inclusion were pregnant women with IUGR babies, estimated fetal weight more than 500g, Gestational age at more than 28 and less than 34 weeks & Singleton pregnancy, with exclusion of multiple gestations & any obvious major structural abnormality.